Hypera Pharma (HYPE3)
BOV
Quarter End | 6 2022 | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
総資産 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
流動資産合計 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
現金および同等物 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
非流動資産合計 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
負債合計 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
流動負債合計 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
非流動負債合計 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
普通株 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
留保所得 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
総資産 | 11.49B | 10.13B | 10.56B | 11.92B | 17.25B | 19.82B | 23.76B | 24.51B |
流動資産合計 | 5.35B | 3.93B | 4.32B | 4.74B | 7.9B | 6.49B | 8.53B | 8.08B |
現金および同等物 | 23.52M | 9.72M | 14.57M | 2.25B | 4.74B | 2.29B | 2.86B | 2.58B |
非流動資産合計 | 8.81B | 7.74B | 8.27B | 8.71B | 9.24B | 9.83B | 10.66B | 11.52B |
負債合計 | 2.67B | 2.39B | 2.29B | 3.21B | 8.01B | 9.98B | 13.1B | 12.99B |
流動負債合計 | 1.74B | 1.71B | 1.42B | 1.59B | 2.63B | 2.78B | 5.23B | 4.64B |
非流動負債合計 | 1.62B | 1B | 1.33B | 2.92B | 10.43B | 14B | 15.25B | 16.16B |
総資本 | 8.81B | 7.74B | 8.27B | 8.71B | 9.24B | 9.83B | 10.66B | 11.52B |
普通株 | 5.27B | 4.45B | 4.45B | 4.45B | 4.48B | 4.48B | 4.48B | 4.48B |
留保所得 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約